-transparent.png){kind=logo}
The results of a study of the CSF concentration of i.v. amoxicillin in control subjects free of meningeal inflammation are presented. The drug proved capable of passing the blood-brain barrier when employed in sufficiently high doses, even in the absence of meningeal inflammation. The CSF level of the antibiotic was higher than the MIC required for most of the meningeal pathogens.
Related Publications
S Mingrino, and
M Scanarini, and
E Magliulo
December 1978,
Antimicrobial agents and chemotherapy,
S Mingrino, and
M Scanarini, and
E Magliulo
September 1986,
Antimicrobial agents and chemotherapy,
S Mingrino, and
M Scanarini, and
E Magliulo
January 1993,
The Japanese journal of antibiotics,
S Mingrino, and
M Scanarini, and
E Magliulo
May 1981,
Drug intelligence & clinical pharmacy,
S Mingrino, and
M Scanarini, and
E Magliulo
August 1988,
The Journal of antimicrobial chemotherapy,
S Mingrino, and
M Scanarini, and
E Magliulo
May 1982,
Neurochirurgia,
S Mingrino, and
M Scanarini, and
E Magliulo
January 1988,
Scandinavian journal of gastroenterology. Supplement,
S Mingrino, and
M Scanarini, and
E Magliulo
January 1951,
Medycyna doswiadczalna i mikrobiologia,
S Mingrino, and
M Scanarini, and
E Magliulo
November 2009,
Antimicrobial agents and chemotherapy,
S Mingrino, and
M Scanarini, and
E Magliulo
April 1986,
European journal of clinical microbiology,
